Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis

Gynecologic Oncology

Volumn 122, Issue 3, 2011, Pages 541-547

  Lee, Yoo Young ^a   Kim, Tae Joong ^a   Kim, Min Ji ^b   Kim, Ha Jeong ^a   Song, Taejong ^a   Kim, Min Kyu ^a   Choi, Chel Hun ^a   Lee, Jeong Won ^a   Bae, Duk Soo ^a   Kim, Byoung Gie ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Clear cell carcinoma; Epithelial ovarian cancer; Prognosis; Survival

Indexed keywords

ADVANCED CANCER; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; DISEASE SEVERITY; EPITHELIAL OVARY CARCINOMA; HAZARD RATIO; HISTOLOGY; HUMAN; META ANALYSIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 80051548022     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.05.009     Document Type: Article

References (46)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. K.J. Krag, G.P. Canellos, C.T. Griffiths, R.C. Knapp, L.M. Parker, and W.R. Welch Predictive factors for long-term survival in patients with advanced ovarian cancer Gynecol Oncol 34 1989 88 93 (Pubitemid 19187970)
3. G.A. Omura, M.F. Brady, H.D. Homesley, E. Yordan, F.J. Major, and H.J. Buchsbaum Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience J Clin Oncol 9 1991 1138 1150
4. E.E. Voest, J.C. van Houwelingen, and J.P. Neijt A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk] as main objectives Eur J Cancer Clin Oncol 25 1989 711 720 (Pubitemid 19096441)
5. R.C. Young, L.A. Walton, S.S. Ellenberg, H.D. Homesley, G.D. Wilbanks, and D.G. Decker Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials N Engl J Med 322 1990 1021 1027 (Pubitemid 20146659)
6. B.A. Goff, R. Sainz de la Cuesta, H.G. Muntz, D. Fleischhacker, M. Ek, and L.W. Rice Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease Gynecol Oncol 60 1996 412 417 (Pubitemid 26077628)
7. D.H. Suh, J.W. Kim, M.F. Aziz, U.K. Devi, H.Y. Ngan, and J.H. Nam Asian society of gynecologic oncology workshop 2010 J Gynecol Oncol 21 2010 137 150
8. D.S. Tan, and S. Kaye Ovarian clear cell adenocarcinoma: a continuing enigma J Clin Pathol 60 2007 355 360 (Pubitemid 46596552)
9. M.K. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 1998 2815 2834 (Pubitemid 28562978)
10. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560 (Pubitemid 37088507)
11. J.K. Chan, D. Teoh, J.M. Hu, J.Y. Shin, K. Osann, and D.S. Kapp Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers Gynecol Oncol 109 2008 370 376
12. N. Einhorn, B. Nilsson, and K. Sjoval Factors influencing survival in carcinoma of the ovary. Study from a well-defined Swedish population Cancer 55 1985 2019 2025 (Pubitemid 15116964)
13. E.L. Jenison, A.G. Montag, C.T. Griffiths, W.R. Welch, P.T. Lavin, and J. Greer Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma Gynecol Oncol 32 1989 65 71 (Pubitemid 19029870)
14. A.W. Kennedy, M. Markman, C.V. Biscotti, J.D. Emery, and L.A. Rybicki Survival probability in ovarian clear cell adenocarcinoma Gynecol Oncol 74 1999 108 114 (Pubitemid 29331176)
15. M. Mizuno, F. Kikkawa, K. Shibata, H. Kajiyama, K. Ino, and M. Kawai Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary J Surg Oncol 94 2006 138 143 (Pubitemid 44267195)
16. D. Pectasides, G. Fountzilas, G. Aravantinos, C. Kalofonos, H. Efstathiou, and D. Farmakis Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience Gynecol Oncol 102 2006 285 291 (Pubitemid 44041640)
17. T. Sugiyama, T. Kamura, J. Kigawa, N. Terakawa, Y. Kikuchi, and T. Kita Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy Cancer 88 2000 2584 2589 (Pubitemid 30331967)
18. P.J. Timmers, A.H. Zwinderman, I. Teodorovic, I. Vergote, and J.B. Trimbos Clear cell carcinoma compared to serous carcinoma in early ovarian cancer: same prognosis in a large randomized trial Int J Gynecol Cancer 19 2009 88 93
19. M.S. Anglesio, M.S. Carey, M. Kobel, H. Mackay, and D.G. Huntsman Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010 Gynecol Oncol 26 2011 26
20. H.J. Mackay, M.F. Brady, A.M. Oza, A. Reuss, E. Pujade-Lauraine, and A.M. Swart Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer Int J Gynecol Cancer 20 2010 945 952
21. M. Kobel, S.E. Kalloger, J.L. Santos, D.G. Huntsman, C.B. Gilks, and K.D. Swenerton Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications Gynecol Oncol 116 2010 50 56
22. S. Serov, R. Scully, and L. Sobin International Histological Classification of Tumors, Number 9 Histologic Typing of Ovarian Tumors 1973 World Health Organization Geneva 1 7
23. M.M. Shevchuk, B. Winkler-Monsanto, C.M. Fenoglio, and R.M. Richart Clear cell carcinoma of the ovary: a clinicopathologic study with review of the literature Cancer 47 1981 1344 1351 (Pubitemid 11090500)
24. M.A. Crozier, L.J. Copeland, E.G. Silva, D.M. Gershenson, and C.A. Stringer Clear cell carcinoma of the ovary: a study of 59 cases Gynecol Oncol 35 1989 199 203 (Pubitemid 19268557)
25. A.W. Kennedy, C.V. Biscotti, W.R. Hart, and K.D. Webster Ovarian clear cell adenocarcinoma Gynecol Oncol 32 1989 342 349 (Pubitemid 19074926)
26. K. Behbakht, T.C. Randall, I. Benjamin, M.A. Morgan, S. King, and S.C. Rubin Clinical characteristics of clear cell carcinoma of the ovary Gynecol Oncol 70 1998 255 258 (Pubitemid 28430939)
27. S. Pather, and M.A. Quinn Clear-cell cancer of the ovary-is it chemosensitive? Int J Gynecol Cancer 15 2005 432 437
28. M. Takano, Y. Kikuchi, N. Yaegashi, K. Kuzuya, M. Ueki, and H. Tsuda Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging Br J Cancer 94 2006 1369 1374 (Pubitemid 43772268)
29. M. Yoonessi, D. Weldon, S.K. Satchidand, and K. Crickard Clear cell ovarian adenocarcinoma J Surg Oncol 27 1984 289 297 (Pubitemid 15179702)
30. R.J. Brescia, N. Dubin, and R.I. Demopoulos Endometrioid and clear cell carcinoma of the ovary. Factors affecting survival Int J Gynecol Pathol 8 1989 132 138 (Pubitemid 19116249)
31. F.O. Recio, M.S. Piver, R.E. Hempling, and D.L. Driscoll Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy Cancer 78 1996 2157 2163 (Pubitemid 26367609)
32. N. Takeshima, Y. Hirai, K. Umayahara, K. Fujiwara, K. Takizawa, and K. Hasumi Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors Gynecol Oncol 99 2005 427 431 (Pubitemid 41502856)
33. C.M. Ho, T.Y. Chien, B.Y. Shih, and S.H. Huang Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma Gynecol Oncol 88 2003 394 399
34. A.G. Montag, E.L. Jenison, C.T. Griffiths, W.R. Welch, P.T. Lavin, and R.C. Knapp Ovarian clear cell carcinoma. A clinicopathologic analysis of 44 cases Int J Gynecol Pathol 8 1989 85 96 (Pubitemid 19116244)
35. T. Kita, Y. Kikuchi, K. Kudoh, M. Takano, T. Goto, and J. Hirata Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary Oncol Rep 7 2000 327 331
36. H. Itamochi, J. Kigawa, and N. Terakawa Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma Cancer Sci 99 2008 653 658 (Pubitemid 351448066)
37. J. Tammela, J.P. Geisler, P.N. Eskew Jr., and H.E. Geisler Clear cell carcinoma of the ovary: poor prognosis compared to serous carcinoma Eur J Gynaecol Oncol 19 1998 438 440 (Pubitemid 28479390)
38. I. Gorai, T. Nakazawa, E. Miyagi, F. Hirahara, Y. Nagashima, and H. Minaguchi Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties Gynecol Oncol 57 1995 33 46
39. W.P. McGuire, W.J. Hoskins, M.F. Brady, P.R. Kucera, E.E. Partridge, and K.Y. Look Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer N Engl J Med 334 1996 1 6 (Pubitemid 26012496)
40. M. Nishida, H. Tsunoda, Y. Ichikawa, and H. Yoshikawa Complete response to irinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell carcinoma Int J Clin Oncol 9 2004 403 405 (Pubitemid 40012711)
41. K. Nishino, Y. Aoki, T. Amikura, H. Obata, M. Sekine, and T. Yahata Irinotecan hydrochloride (CPT-11) and mitomycin C as the first line chemotherapy for ovarian clear cell adenocarcinoma Gynecol Oncol 97 2005 893 897 (Pubitemid 40824662)
42. T. Sugiyama, S. Kumagai, and S. Hatayama Treatments of epithelial ovarian cancer by histologic subtype Gan To Kagaku Ryoho 36 2009 187 192
43. R. Vang, M. Shih Ie, and R.J. Kurman Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems Adv Anat Pathol 16 2009 267 282
44. A.P. Heintz, F. Odicino, P. Maisonneuve, M.A. Quinn, J.L. Benedet, and W.T. Creasman Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer Int J Gynaecol Obstet 95 Suppl 1 2006 S161 S192
45. I. Skirnisdottir, T. Seidal, M.G. Karlsson, and B. Sorbe Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II Int J Oncol 26 2005 177 183
46. D. Pectasides, E. Pectasides, A. Psyrri, and T. Economopoulos Treatment issues in clear cell carcinoma of the ovary: a different entity? Oncologist 11 2006 1089 1094 (Pubitemid 44788400)